nc-4016
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2013 (NCT03168035)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- DNACROSS-LINKING AGENT
DNA cross-linking agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nc-4016
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01999491 | Phase 1 | Nov 4, 2013 | NanoCarrier Co., Ltd., University of Texas at Houston |
| NCT03168035 | Phase 1 | Nov 1, 2013 | NanoCarrier Co., Ltd., University of Texas at Houston |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| NanoCarrier Co., Ltd. | For profit | 2 | 1 | 1 | 2013 |
| University of Texas at Houston | Academic/Hospital | 2 | 1 | 1 | 2013 |
2 organizations
Page 1 / 1